Table 2.

Number of cats (10/group) with peripheral circulating eosinophilia (>1500/μL) after L3 D. immitis infection

	Day 0		Day 70		Day 110		Day 168		Day 240		Day 300		Day 390		Day 505
	> 1500	Range	> 1500	Range	> 1500	Range	> 1500	Range	> 1500	Range	> 1500	Range	> 1500	Range	> 1500	Range
Group A	0	267–1395	2	190–6511	4	241–1915	2	95–1564	0	503–1286	0	178–1064	1	327–1771	0	0–994
Group B	0	317–1450	6	206–14,891	8	757–5594	2	218–3400	4	419–1654	1	228–1600	1	338–1828	0	0–1105
Group C	0	87–1400	3	137–5880	7	137–2025	7	519–8831	8	586–7454	6	941–6334	8	831–10,620	7	184–5264

Group A: selamectin topical initiated on Day 28 PI; Group B: oral ivermectin initiated on Day 70 PI; Group C: infected, no treatment (9 cats in group Day 240–505)